Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-15-162573
Filing Date
2015-04-30
Accepted
2015-04-30 17:05:36
Documents
9
Effectiveness Date
2015-04-30

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS d913908ddefa14a.htm DEFA14A 44210
2 GRAPHIC g913908page003a.jpg GRAPHIC 15089
3 GRAPHIC g913908page003b.jpg GRAPHIC 10781
4 GRAPHIC g913908page004a.jpg GRAPHIC 13488
5 GRAPHIC g913908page004b.jpg GRAPHIC 13770
6 GRAPHIC g913908page004c.jpg GRAPHIC 13752
7 GRAPHIC g913908page004d.jpg GRAPHIC 10834
8 GRAPHIC g913908page005.jpg GRAPHIC 10568
9 GRAPHIC g913908page006.jpg GRAPHIC 10569
  Complete submission text file 0001193125-15-162573.txt   182830
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-24006 | Film No.: 15820044
SIC: 2834 Pharmaceutical Preparations